{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:16:53Z","timestamp":1794644213027,"version":"4.9.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1584-1","type":"journal-article","created":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T12:51:05Z","timestamp":1465822265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["A Synthesis of Hepatitis C prevalence estimates in Sub-Saharan Africa: 2000\u20132013"],"prefix":"10.1186","volume":"16","author":[{"given":"Nallely","family":"Mora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Kliethermes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Dugas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Nde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Jose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Scaglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Layden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,13]]},"reference":[{"issue":"Suppl 1","key":"1584_CR1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1478-3231.2008.01934.x","volume":"29","author":"D Lavanchy","year":"2009","unstructured":"Lavanchy D. The global burden of hepatitis C. Liver Int. 2009;29 Suppl 1:74\u201381.","journal-title":"Liver Int"},{"key":"1584_CR2","unstructured":"A SPECIAL MEETING REVIEW EDITION: Advances in the Treatment of Hepatitis C Virus Infection from The Liver Meeting 2013: The 64th Annual Meeting of the American Association for the Study of Liver DiseasesNovember 1\u20135, 2013* Washington DCSpecial Reporting on:* Simeprevir plus Sofosbuvir with or without Ribavirin Produces High SVR Rates in Genotype 1 HCV Infection* Novel Interferon- and Ribavirin-Free Regimen Results in SVR12 Rates of Over 90 % in HCV Genotype 1b Infection* Studies Confirm Efficacy of Adjunctive Simeprevir in Difficult-to-Treat HCV Genotype 1 Subpopulations* All-Oral Therapy with Sofosbuvir Plus Ribavirin Produces High SVR Rates in Patients Coinfected with HCV and HIV* Faldaprevir Combined with Pegylated Interferon and Ribavirin Demonstrates High Efficacy in DifficuIt-to-Treat HCV Infection* Once Daily Sofosbuvir\/Ledipasvir Combination Elicits Rapid Decline in HCV RNAPLUS Meeting Abstract Summaries With Expert Commentary by: Ira M. Jacobson, MDWeill Cornell Medical CollegeNew York, New York. Gastroenterol Hepatol (N Y). 2014;10(1 Suppl 1):1\u201319."},{"issue":"4","key":"1584_CR3","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","volume":"57","author":"K Mohd Hanafiah","year":"2013","unstructured":"Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333\u201342.","journal-title":"Hepatology"},{"issue":"1 Suppl","key":"1584_CR4","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","volume":"61","author":"E Gower","year":"2014","unstructured":"Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(1 Suppl):S45\u201357.","journal-title":"J Hepatol"},{"issue":"7","key":"1584_CR5","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1473-3099(15)00006-7","volume":"15","author":"VB Rao","year":"2015","unstructured":"Rao VB, Johari N, du Cros P, Messina J, Ford N, Cooke GS. Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Infect Dis. 2015;15(7):819\u201324.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1584_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.1093","volume":"65","author":"D Candotti","year":"2001","unstructured":"Candotti D, Mundy C, Kadewele G, Nkhoma W, Bates I, Allain JP. Serological and molecular screening for viruses in blood donors from Ntcheu, Malawi: high prevalence of HIV-1 subtype C and of markers of hepatitis B and C viruses. J Med Virol. 2001;65(1):1\u20135.","journal-title":"J Med Virol"},{"issue":"5","key":"1584_CR7","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1537-2995.2006.00789.x","volume":"46","author":"H Scheiblauer","year":"2006","unstructured":"Scheiblauer H, El-Nageh M, Nick S, Fields H, Prince A, Diaz S. Evaluation of the performance of 44 assays used in countries with limited resources for the detection of antibodies to hepatitis C virus. Transfusion. 2006;46(5):708\u201318.","journal-title":"Transfusion"},{"issue":"12","key":"1584_CR8","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/cid\/cit602","volume":"57","author":"CE Mullis","year":"2013","unstructured":"Mullis CE, Laeyendecker O, Reynolds SJ, Ocama P, Quinn J, Boaz I, et al. High frequency of false-positive hepatitis C virus enzyme-linked immunosorbent assay in Rakai, Uganda. Clin Infect Dis. 2013;57(12):1747\u201350.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1584_CR9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1473-3099(02)00264-5","volume":"2","author":"V Madhava","year":"2002","unstructured":"Madhava V, Burgess C, Drucker E. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis. 2002;2(5):293\u2013302.","journal-title":"Lancet Infect Dis"},{"key":"1584_CR10","doi-asserted-by":"crossref","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283(15):2008.","DOI":"10.1001\/jama.283.15.2008"},{"key":"1584_CR11","volume-title":"Coountry Classification.Data soources, country classifications and aggregation methodology","author":"UN\/DESA","year":"2014","unstructured":"UN\/DESA. Coountry Classification.Data soources, country classifications and aggregation methodology. 2014."},{"key":"1584_CR12","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1037\/1082-989X.3.4.486","volume":"3","author":"L Hedges","year":"1998","unstructured":"Hedges L, Veva J. Fixed- and random-effects models in meta-analysis. Psychol Methods. 1998;3:486\u2013504.","journal-title":"Psychol Methods"},{"key":"1584_CR13","unstructured":"United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects: The 2015 Revision, Key Findings and Advance Tables. Working Paper No. ESA\/P\/WP.241. 2015. https:\/\/esa.un.org\/unpd\/wpp\/Publications\/Files\/Key_Findings_WPP_2015.pdf ."},{"issue":"3","key":"1584_CR14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/itdj.20015","volume":"11","author":"B Chilundo","year":"2005","unstructured":"Chilundo B, Sahay S. HIV\/AIDS reporting systems in Mozambique: The theoretical and empirical challenges of \u201crepresentations\u201d. Inf Technol Dev. 2005;11(3):245\u201372.","journal-title":"Inf Technol Dev"},{"issue":"12","key":"1584_CR15","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/jmv.21010","volume":"79","author":"L Cunha","year":"2007","unstructured":"Cunha L, Plouzeau C, Ingrand P, Gudo JP, Ingrand I, Mondlane J, et al. Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique. J Med Virol. 2007;79(12):1832\u201340.","journal-title":"J Med Virol"},{"key":"1584_CR16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2458-13-50","volume":"13","author":"W Baha","year":"2013","unstructured":"Baha W, Foullous A, Dersi N, They-they TP, El alaoui K, Nourichafi N, et al. Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco. BMC Public Health. 2013;13:50.","journal-title":"BMC Public Health"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1584-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T16:16:49Z","timestamp":1498321009000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1584-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,13]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1584"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1584-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,13]]},"article-number":"283"}}